Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania

Clin Chim Acta. 2017 May:468:25-31. doi: 10.1016/j.cca.2017.01.029. Epub 2017 Jan 31.

Abstract

Background: The bioactive signaling lipid sphingosine-1-phosphate (S1P) is a potential biomarker for cardiovascular disease (CVD). To date, no reference intervals for S1P have been defined. This study aims to establish a reference range for serum S1P in healthy individuals.

Methods: We determined reference intervals for S1P levels according to gender and age in a sample of 1339 healthy participants of the Study of Health in Pomerania (SHIP)-TREND cohort after exclusion of subjects with CVD, diabetes mellitus, hypertension, metabolic syndrome, elevated liver enzymes, chronic kidney disease stadium III or IV, or body mass index (BMI)>30kg/m2. Serum S1P was measured by liquid chromatography-tandem mass spectrometry.

Results: The median age of the participants was 41 (25th; 75th percentile 32; 51) years, 65% were women. The median serum concentration of S1P was 0.804 (0.694; 0.920) μmol/L. No association with gender and age was observed. The overall reference interval was 0.534-1.242μmol/L (2.5th; 97.5th percentile). Further exclusion of smokers, individuals with BMI>25kg/m2 or elevated lipid levels did not significantly affect median S1P concentrations.

Conclusions: This study provides reference intervals for serum S1P in healthy individuals. Total serum S1P concentrations vary irrespectively of age, gender, BMI or smoking status.

Keywords: Reference intervals; Sphingosine-1-phosphate; Study of Health in Pomerania.

MeSH terms

  • Adult
  • Blood Chemical Analysis / standards*
  • Female
  • Germany
  • Health Surveys*
  • Humans
  • Lysophospholipids / blood*
  • Male
  • Sphingosine / analogs & derivatives*
  • Sphingosine / blood

Substances

  • Lysophospholipids
  • sphingosine 1-phosphate
  • Sphingosine